Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.

Summary

This study is looking to determine if Lumateperone improves motivation in patients with schizophrenia or schizoaffective disorders who show high levels of apathy as judged by AES-C-Apathy (Apathy Evaluation Scale - Clinician - Apathy) assessment and to examine a possible correlation between improvement in apathy scores and changes in elements of the PANSS (Positive and Negative Syndrome Scale) due to treatment with Lumateperone.

Timeline

Start

2024-06

Primary completion

2026-12

Completion

2026-12

Drugs

Indications